Highlight
Free Access
Issue
Dairy Sci. Technol.
Volume 88, Number 4-5, July-October 2008
5th Symposium on Cheese Ripening
Page(s) 389 - 405
DOI https://doi.org/10.1051/dst:2008012
Published online 02 October 2008
References of  Dairy Sci. Technol. 88 (2008) 389–405
  1. Allender P.S., Cutler J.A., Follmann D., Cappuccio F.P., Pryer J., Elliott P., Dietary calcium and blood pressure: a meta-analysis of randomized clinical trials, Ann. Intern. Med. 124 (1996) 825–831 [PubMed].
  2. Appel L.J., Moore T.J., Obarzanek E., Vollmer W.M., Svetkey L.P., Sacks F.M., Bray G.A., Vogt T.M., Cutler J.A., Windhauser M.M., Lin P.H., Karanja N., A clinical trial of the effects of dietary patterns on blood pressure, N. Engl. J. Med. 336 (1997) 1117–1124 [CrossRef] [PubMed].
  3. Ashley F.P., Coward P.Y., Jalil R.A., Wilson R.F., Relationship between calcium and inorganic phosphorus concentrations of both resting and stimulated saliva and dental plaque in children and young adults, Arch. Oral Biol. 36 (1991) 431–434 [CrossRef] [PubMed].
  4. Bachmann H.P., Bütikofer U., Sieber R., Über das Vorkommen von bioaktiven Peptiden in Käse, Mitt. Lebensm. Hyg. 94 (2003) 136–154.
  5. Behn A., Ur E., The obesity epidemic and its cardiovascular consequences, Curr. Opin. Cardiol. 21 (2006) 353–360 [CrossRef] [PubMed].
  6. Belury M.A., Inhibition of carcinogenesis by conjugated linoleic acid: Potential mechanisms of action, J. Nutr. 132 (2002) 2995–2998 [PubMed].
  7. Bizik B.K., Ding W., Cerklewski F.L., Evidence that bone resorption of young men is not increased by high dietary phosphorus obtained from milk and cheese, Nutr. Res. 16 (1996) 1143–1146 [CrossRef].
  8. Boursier V., Metabolic syndrome, J. Mal. Vasc. 31 (2006) 190–201 [CrossRef] [PubMed].
  9. Braun S.D., Nimmagudda R., Methods for treating or preventing diseases of the oral cavity, US Patent 6890900 (2005).
  10. Bucher H.C., Cook R.J., Guyatt G.H., Lang J.D., Cook D.J., Hatala R., Hunt D.L., Effects of dietary calcium supplementation on blood pressure: a meta-analysis of randomized controlled trials, J. Am. Med. Ass. 275 (1996) 1016–1022 [CrossRef].
  11. Bütikofer U., Meyer J., Sieber R., Walther B., Wechsler D., Occurrence of the angiotensin-converting enzyme-inhibiting tripeptides Val-Pro-Pro and Ile-Pro-Pro in different cheese varieties of Swiss origin, J. Dairy Sci. 91 (2008) 29–38 [CrossRef] [PubMed].
  12. Bütikofer U., Meyer J., Sieber R., Wechsler D., Quantification of the angiotensin-converting enzyme-inhibiting tripeptides Val-Pro-Pro and Ile-Pro-Pro in hard, semi-hard and soft cheeses, Int. Dairy J. 17 (2007) 968–975 [CrossRef].
  13. Chardigny J.M., Destaillat F., Malpuech-Brugère C., Moulin J., Bauman D.E., Lock A.L., Barbano D.M., Mensink R.P., Bezelgues J.B., Chaumont P., Combe N., Cristiani I., Joffre F., German J.B., Dionisi F., Boirie Y., Sébédio J.L., Do trans fatty acids from industrially produced sources and from natural sources have the same effect on cardiovascular disease risk factors in healthy subjects? Results of the trans Fatty Acids Collaboration (TRANSFACT) study, Am. J. Clin. Nutr. 87 (2008) 558–566 [PubMed].
  14. Cheng S., Lyytikainen A., Kroger H., Lamberg-Allardt C., Alen M., Koistinen A., Wang Q.J., Suuriniemi M., Suominen H., Mahonen A., Nicholson P.H.F., Ivaska K.K., Korpela R., Ohlsson C., Vaananen K.H., Tylavsky F., Effects of calcium, dairy product, and vitamin D supplementation on bone mass accrual and body composition in 10-12-y-old girls: a 2-y randomized trial, Am. J. Clin. Nutr. 82 (2005) 1115–1126 [PubMed].
  15. Colakoglu S., Colakoglu M., Taneli F., Cetinoz F., Turkmen M., Cumulative effects of conjugated linoleic acid and exercise on endurance development, body composition, serum leptin and insulin levels, J. Sports Med. Phys. Fitness 46 (2006) 570–577 [PubMed].
  16. Collomb M., Bütikofer U., Sieber R., Bosset J.O., Jeangros B., Conjugated linoleic acid and trans fatty acid composition of cows' milk fat produced in lowlands and highlands, J. Dairy Res. 68 (2001) 519–523 [CrossRef] [PubMed].
  17. Djoussé L., Pankow J.S., Hunt S.C., Heiss G., Province M.A., Kabagambe E.K., Ellison R.C., Influence of saturated fat and linolenic acid on the association between intake of dairy products and blood pressure, Hypertension 48 (2006) 335–341 [CrossRef] [PubMed].
  18. Dreizen S.A.M.U., Dreizen J.G., Stone R.E., The effect of cow's milk on dental caries in the rat, J. Dent. Res. 40 (1961) 1025–1028.
  19. Edgar W.M., Bowen W.H., Amsbaugh S., Monell-Torrens E., Brunelle J., Effects of different eating patterns on dental caries in the rat, Caries Res. 16 (1982) 384–389 [PubMed].
  20. Eichholzer M., Camenzind E., Matzke A., Amadò R., Ballmer P.E., Beer M., Darioli R., Hasler K., Lüthy J., Moser U., Sieber R., Trabichet C., Fünfter Schweizerischer Ernährungsbericht, Bundesamt für Gesund-heit, Bern, 2005.
  21. Foltz M., Meynen E.E., Bianco V., van Platerink C., Koning T.M.M.G., Kloek J., Angiotensin converting enzyme inhibitory peptides from a lactotripeptide-enriched milk beverage are absorbed intact into the circulation, J. Nutr. 137 (2007) 953–958 [PubMed].
  22. Fox P.F., O'Connor T.P., McSweeney P.L.H., Guinee T.P., O'Brien N.M., Cheese: physical, biochemical, and nutritional aspects, Adv. Food Nutr. Res. 39 (1995) 163–328.
  23. German J.B., Dillard C.J., Saturated fats: what dietary intake?, Am. J. Clin. Nutr. 80 (2004) 550–559 [PubMed].
  24. Glabska D., Sinska B., Remiszewski A., [Analysis of the dependence between milk and dairy products consumption, and dental caries observed in group of children and teenagers], Rocz. Panstw. Zakl. Hig. 58 (2007) 69–75 [PubMed].
  25. Gómez-Ruiz J.Á., Ramos M., Recio I., Angiotensin-converting enzyme-inhibitory peptides in Manchego cheeses manufactured with different starter cultures, Int. Dairy J. 12 (2002) 697–706 [CrossRef].
  26. Gómez-Ruiz J.Á., Ramos M., Recio I., Identification and formation of angiotensin-converting enzyme-inhibitory peptides in Manchego cheese by high-performance liquid chromatography-tandem mass spectrometry, J. Chromatogr. A 1054 (2004) 269–277 [CrossRef] [PubMed].
  27. Gómez-Ruiz J.Á., Taborda G., Amigo L., Recio I., Ramos M., Identification of ACE-inhibitory peptides in different Spanish cheeses by tandem mass spectrometry, Eur. Food Res. Technol. 223 (2006) 595–601 [CrossRef].
  28. Guggenheim B., Schmid R., Aeschlimann J.M., Berrocal R., Neeser J.R., Powdered milk micellar casein prevents oral colonization by Streptococcus sobrinus and dental caries in rats: A basis for the caries-protective effect of dairy products, Caries Res. 33 (1999) 446–454 [CrossRef] [PubMed].
  29. Hata Y., Yamamoto M., Ohni M., Nakajima K., Nakamura Y., Takano T., A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects, Am. J. Clin. Nutr. 64 (1996) 767–771 [PubMed].
  30. Hayes K.C., Pronczuk A., Lindsey S., Diersenschade D., Dietary saturated fatty acids (12:0, 14:0, 16:0) differ in their impact on plasma cholesterol and lipoproteins in nonhuman primates, Am. J. Clin. Nutr. 53 (1991) 491–498 [PubMed].
  31. Heaney R.P., Calcium, dairy products and osteoporosis, J. Am. Coll. Nutr. 19 (2000) 83S–99S [PubMed].
  32. Heaney R.P., Calcium intake and disease prevention, Arq. Bras. Endocrinol. Metabol. 50 (2006) 685–693 [PubMed].
  33. Henry H.J., McCarron D.A., Morris C.D., Parrott-Garcia M., Increasing calcium intake lowers blood pressure: the literature reviewed, J. Am. Diet. Assoc. 85 (1985) 182–185 [PubMed].
  34. Heyman M.B., for the Committee on nutrition, Lactose intolerance in infants, children, and adolescents, Pediatrics 118 (2006) 1279–1286 [CrossRef] [PubMed].
  35. Higurashi S., Kunieda Y., Matsuyama H., Kawakami H., Effect of cheese consumption on the accumulation of abdominal adipose and decrease in serum adiponectin levels in rats fed a calorie dense diet, Int. Dairy J. 17 (2007) 1224–1231 [CrossRef].
  36. Huang T.T., McCrory M.A., Dairy intake, obesity, and metabolic health in children and adolescents: knowledge and gaps, Nutr. Rev. 63 (2005) 71–80 [CrossRef] [PubMed].
  37. IDF, The world dairy situation 2006, 409 (2006) 1–92.
  38. IDF, The world dairy situation 2007, 423 (2007) 1–97.
  39. Jakobsen M.U., Overvad K., Dyerberg J., Heitmann B.L., Intake of ruminant trans fatty acids and risk of coronary heart disease, Int. J. Epidemiol. 37 (2008) 173–182 [CrossRef] [PubMed].
  40. Jenkins G.N., Ferguson D.B., Milk and dental caries, Brit. Dent. J. 120 (1966) 472–477.
  41. Jensen M.E., Donly K., Wefel J.S., Assessment of the effect of selected snack foods on the remineralization/ demineralization of enamel and dentin, J. Contemp. Dent. Pract. 1 (2000) 1–17.
  42. Jensen M.E., Harlander S.K., Schachtele C.F., Evaluation of the acidogenic and antacid properties of cheeses by telemetric monitoring of human dental plaque pH, in: Hefferren J.J., Osborn J.C., Koehler H.M. (Eds.), Foods, Nutrition and Dental Health, American Dental Association, Chicago, USA, 1984, pp. 31–47.
  43. Kato K., Takada Y., Matsuyama H., Kawasaki Y., Aoe S., Yano H., Toba Y., Milk calcium taken with cheese increases bone mineral density and bone strength in growing rats, Biosci. Biotechnol. Biochem. 66 (2002) 2342–2346 [CrossRef] [PubMed].
  44. Lam G.A., Mobarhan S., Central obesity and elevated liver enzymes, Nutr. Rev. 62 (2004) 394–399 [CrossRef] [PubMed].
  45. Larsen T.M., Toubro S., Gudmundsen O., Astrup A., Conjugated linoleic acid supplementation for 1 y does not prevent weight or body fat regain, Am. J. Clin. Nutr. 83 (2006) 606–612 [PubMed].
  46. Laso N., Brugué E., Vidal J., Ros E., Arnaiz J.A., Carné X., Vidal S., Mas S., Deulofeu R., Lafuente A., Effects of milk supplementation with conjugated linoleic acid (isomers cis-9, trans-11 and trans-10, cis-12) on body composition and metabolic syndrome components, Brit. J. Nutr. 98 (2007) 860–867 [CrossRef].
  47. Law B.A., Flavour development in cheeses, in: Davies F.L., Law B.A. (Eds.), Advances in the microbiology and biochemistry of cheese and fermented milk, Elsevier Appl. Sci. Publ., London, UK, 1984, pp. 187–208.
  48. Li G.H., Le G.W., Shi Y.H., Shrestha S., Angiotensin I-converting enzyme inhibitory peptides derived from food proteins and their physiological and pharmacological effects, Nutr. Res. 24 (2004) 469–486.
  49. Lin Y.C., Lyle R.M., McCabe L.D., McCabe G.P., Weaver C.M., Teegarden D., Dairy calcium is related to changes in body composition during a two-year exercise intervention in young women, J. Am. Coll. Nutr. 19 (2000) 754–760 [PubMed].
  50. Massey L.K., Dairy food consumption, blood pressure and stroke, J. Nutr. 131 (2001) 1875–1878 [PubMed].
  51. Masuda O., Nakamura Y., Takano T., Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats, J. Nutr. 126 (1996) 3063–3068 [PubMed].
  52. Matlik L., Savaiano D., McCabe G., VanLoan M., Blue C.L., Boushey C.J., Perceived milk intolerance is related to bone mineral content in 10- to 13-year-old female adolescents, Pediatrics 120 (2007) e669–e677.
  53. McCarron D.A., Reusser M.E., Hypertensive cardiovascular disease: risk reduction by dietary calcium and dairy foods, Sci. Alim. 22 (2002) 415–421 [CrossRef].
  54. Meisel H., Walsh D.J., Murray B., FitzGerald R.J., ACE inhibiting peptides, in: Mine Y., Shahidi F. (Eds.), Nutraceutical proteins and peptides in health and disease, CRC Press, Boca Raton, USA, 2006, pp. 269–315.
  55. Metz J.A., Morris C.D., Roberts L.A., McClung M.R., McCarron D.A., Blood pressure and calcium intake are related to bone density in adult males, Brit. J. Nutr. 81 (1999) 383–388.
  56. Miller G.D., DiRienzo D.D., Reusser M.E., McCarron D.A., Benefits of dairy product consumption on blood pressure in humans: a summary of the biomedical literature, J. Am. Coll. Nutr. 19 (2000) 147S–164S [PubMed].
  57. Mizushima S., Ohshige K., Watanabe J., Kimura M., Kadowaki T., Nakamura Y., Tochikubo O., Ueshima H., Randomized controlled trial of sour milk on blood pressure in borderline hypertensive men, Am. J. Hypertens. 17 (2004) 701–706 [CrossRef] [PubMed].
  58. Molimard P., Spinnler H.E., Review: compounds involved in the flavor of surface mold-ripened cheeses: origins and properties, J. Dairy Sci. 79 (1996) 169–184.
  59. Mourao D.M., Bressan J., Campbell W.W., Mattes R.D., Effects of food form on appetite and energy intake in lean and obese young adults, Int. J. Obes. 31 (2007) 1688–1695 [CrossRef].
  60. Moynihan P.J., Ferrier S., Jenkins G.N., The cariostatic potential of cheese: cooked cheese-containing meals increase plaque calcium concentration, Brit. Dent. J. 187 (1999) 664–667 [CrossRef].
  61. Nagpal R., Yadav H., Puniya A.K., Singh K., Jain S., Marotta F., Conjugated linoleic acid: sources, synthesis and potential health benefits – an overview, Curr. Topics Nutraceut. Res. 5 (2007) 55–65.
  62. Nakamura Y., Kajimoto O., Kaneko K., Aihara K., Mizutani J., Ikeda N., Nishimura A., Kajimoto Y., Effects of the liquid yogurts containing “lactotripeptide (VPP, IPP)” on high-normal blood pressure, J. Nutr. Food 7 (2004) 123–137.
  63. Nakamura Y., Yamamoto N., Sakai K., Takano T., Antihypertensive effect of sour milk and peptides isolated from it that are inhibitors to angiotensin I-converting enzyme, J. Dairy Sci. 78 (1995) 1253–1257 [PubMed].
  64. Nammi S., Koka S., Chinnala K.M., Boini K.M., Obesity: an overview on its current perspectives and treatment options, Nutr. J. 3 (2004) 3–10 [CrossRef] [PubMed].
  65. Narva M., Rissanen J., Halleen J., Vapaatalo H., Väänänen K., Korpela R., Effects of bioactive peptide, Valyl-Prolyl-Proline (VPP), and Lactobacillus helveticus fermented milk containing VPP on bone loss in ovariectomized rats, Ann. Nutr. Metab. 51 (2007) 65–74 [CrossRef] [PubMed].
  66. Ouignard-Boulange A., Clouet P., Schmitt B., Effects of dietary conjugated linoleic acids in the control of adiposity and obesity-related disorders, Eur. J. Lipid Sci. Technol. 109 (2007) 935–944 [CrossRef].
  67. Pan D., Luo Y.K., Tanokura M., Antihypertensive peptides from skimmed milk hydrolysate digested by cell-free extract of Lactobacillus helveticus JCM1004, Food Chem. 91 (2005) 123–129 [CrossRef].
  68. Pariza M.W., Perspective on the safety and effectiveness of conjugated linoleic acid, Am. J. Clin. Nutr. 79 (2004) 1132S–1136S [PubMed].
  69. Pi-Sunyer F.X., Health implications of obesity, Am. J. Clin. Nutr. 53 (1991) 1595S–1603S [PubMed].
  70. Pludowski P., Litwin M., Sladowska J., Antoniewicz J., Niemirska A., Wierzbicka A., Lorenc R.S., Bone mass and body composition in children and adolescents with primary hypertension: preliminary data, Hypertension 51 (2008) 77–83 [CrossRef] [PubMed].
  71. Reynolds E.C., Johnson I.H., Effect of milk on caries incidence and bacterial composition of dental plaque in the rat, Arch. Oral Biol. 26 (1981) 445–451 [CrossRef] [PubMed].
  72. Rioux V., Catheline D., Bouriel M., Legrand P., Dietary myristic acid at physiologically relevant levels increases the tissue content of C20:5 n-3 and C20:3 n-6 in the rat, Reprod. Nutr. Dev. 45 (2005) 599–612 [CrossRef] [PubMed] [EDP Sciences].
  73. Rioux V., Daval S., Guillou H., Jan S., Legrand P., Although it is rapidly metabolized in cultured rat hepatocytes, lauric acid is used for protein acylation, Reprod. Nutr. Dev. 43 (2003) 419–430 [CrossRef] [PubMed] [EDP Sciences].
  74. Rioux V., Legrand P., Saturated fatty acids: simple molecular structures with complex cellular functions, Curr. Opin. Clin. Nutr. Metab. Care 10 (2007) 752–758 [PubMed].
  75. Rosell M., Hakansson N.N., Wolk A., Association between dairy food consumption and weight change over 9 y in 19 352 perimenopausal women, Am. J. Clin. Nutr. 84 (2006) 1481–1488 [PubMed].
  76. Roth J., Qiang X., Marban S.L., Redelt H., Lowell B.C., The obesity pandemic: where have we been and where are we going?, Obes. Res. 12 (2004) 88S–101S [CrossRef] [PubMed].
  77. Rugg-Gunn A.J., Edgar W.M., Geddes D.A.M., Jenkins G.N., The effect of different meal patterns upon plaque pH in human subjects, Br. Dent. J. 139 (1975) 351–356 [CrossRef] [PubMed].
  78. Ruidavets J.B., Bongard V., Simon C., Dallongeville J., Ducimetiere P., Arveiler D., Amouyel P., Bingham A., Ferrieres J., Independent contribution of dairy products and calcium intake to blood pressure variations at a population level, J. Hypertens. 24 (2006) 671–681 [CrossRef] [PubMed].
  79. Sacks F.M., Svetkey L.P., Vollmer W.M., Appel L.J., Bray G.A., Harsha D., Obarzanek E., Conlin P.R., Miller E.R., Simons-Morton D.G., Karanja N., Lin P.H., Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet, N. Engl. J. Med. 344 (2001) 3–10 [CrossRef] [PubMed].
  80. Saito T., Nakamura T., Kitazawa H., Kawai Y., Itoh T., Isolation and structural analysis of antihypertensive peptides that exist naturally in Gouda cheese, J. Dairy Sci. 83 (2000) 1434–1440 [PubMed].
  81. Salter A.M., Mangiapane E.H., Bennett A.J., Bruce J.S., Billett M.A., Anderton K.L., Marenah C.B., Lawson N., White D.A., The effect of different dietary fatty acids on lipoprotein metabolism: concentration-dependent effects of diets enriched in oleic, myristic, palmitic and stearic acids, Brit. J. Nutr. 79 (1998) 195–202 [CrossRef].
  82. Schmid A., Schneider H., Golay A., Keller U., Economic burden of obesity and its comorbidities in Switzerland, Soz. Präventivmed. 50 (2005) 87–94 [CrossRef] [PubMed].
  83. Schramm M.M., Cauley J.A., Sandler R.B., Slemenda C.W., Lack of an association between calcium intake and blood pressure in postmenopausal women, Am. J. Clin. Nutr. 44 (1986) 505–511 [PubMed].
  84. Seppo L., Jauhiainen T., Poussa T., Korpela R., A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects, Am. J. Clin. Nutr. 77 (2003) 326–330 [PubMed].
  85. Shimizu H., Nakagami H., Osako M.K., Hanayama R., Kunugiza Y., Kizawa T., Tomita T., Yoshikawa H., Ogihara T., Morishita R., Angiotensin II accelerates osteoporosis by activating osteoclasts, FASEB J. 22 (2008) 2465–2475 [CrossRef] [PubMed].
  86. Sieber R., Zusammensetzung von Milch und Milchprodukten schweizerischer Herkunft, FAM-Information (2001) 1–23, available at http://www.db-alp.admin.ch/de/publikationen/docs/pub_SieberR_2001_15231.pdf.
  87. Sieber R., Käse – ein wertvolles Lebensmittel in der menschlichen Ernährung, Mitt. Lebensm. Hyg. 96 (2005) 141–170.
  88. Sieber R., Badertscher R., Fuchs D., Nick B., Beitrag zur Kenntnis der Zusammensetzung schweizerischer konsumreifer Weich- und Halbhartkäse, Mitt. Geb. Lebensm.-Unters. -Hyg. 85 (1994) 366–381.
  89. Sieber R., Stransky M., de Vrese M., Laktoseintoleranz und Verzehr von Milch und Milchprodukten, Z. Ernährungswiss. 36 (1997) 375–393 [CrossRef] [PubMed].
  90. Silva S.V., Pihlanto A., Malcata F.X., Bioactive peptides in ovine and caprine cheeselike systems prepared with proteases from Cynara cardunculus, J. Dairy Sci. 89 (2006) 3336–3344 [PubMed].
  91. Silveira M.B., Carraro R., Monereo S., Tebar J., Conjugated linoleic acid (CLA) and obesity, Public Health Nutr. 10 (2007) 1181–1186 [CrossRef] [PubMed].
  92. Simon J.A., Browner W.S., Tao J.L., Hulley S.B., Calcium intake and blood pressure in elderly women, Am. J. Epidemiol. 136 (1992) 1241–1247 [PubMed].
  93. Sipola M., Finckenberg P., Korpela R., Vapaatalo H., Nurminen M.L., Effect of long-term intake of milk products on blood pressure in hypertensive rats, J. Dairy Res. 69 (2002) 103–111 [CrossRef] [PubMed].
  94. Smacchi E., Gobbetti M., Peptides from several Italian cheeses inhibitory to proteolytic enzymes of lactic acid bacteria, Pseudomonas fluorescens ATCC 948 and to the angiotensin I-converting enzyme, Enzyme Microb. Technol. 22 (1998) 687–694 [CrossRef].
  95. Snijder M.B., van der Heijden A., van Dam R.M., Stehouwer C.D.A., Hiddink G.J., Nijpels G., Heine R.J., Bouter L.M., Dekker J.M., Is higher dairy consumption associated with lower body weight and fewer metabolic disturbances? The Hoorn Study, Am. J. Clin. Nutr. 85 (2007) 989–995 [PubMed].
  96. Steffen C., Enzymatische Bestimmung-smethoden zur Erfassung der Gärung-svorgänge in der milchwirtschaftlichen Technologie, Lebensm.-Wiss. Technol. 8 (1975) 1–6.
  97. Stepaniak L., Jedrychowski L., Wroblewska B., Sørhaug T., Immuno-reactivity and inhibition of angiotensin-I converting enzyme and lactococcal oligo-peptidase by peptides from cheese, Ital. J. Food Sci. 13 (2001) 373–381.
  98. Subcommittee on the 10th Edition of the Recommended Dietary Allowances, Food and Nutrition Board, National Research Council, Recommended Dietary Allowances, National Academic Press, 1989.
  99. Temme E.H.M., Mensink R.P., Hornstra G., Comparison of the effects of diets enriched in lauric, palmitic, or oleic acids on serum lipids and lipoproteins in healthy women and men, Am. J. Clin. Nutr. 63 (1996) 897–903 [PubMed].
  100. Terpstra A.H., Effect of conjugated linoleic acid on body composition and plasma lipids in humans: an overview of the literature, Am. J. Clin. Nutr. 79 (2004) 352–361 [PubMed].
  101. Tomé D., Bos C., Mariotti F., Gaudichon C., Protein quality and FAO/WHO recommendations, Sci. Alim. 22 (2002) 393–405 [CrossRef].
  102. Trevisan M., Krogh V., Farinaro E., Panico S., Mancini M., Calcium-rich foods and blood pressure: findings from the Italian National Research Council Study (the Nine Communities Study), Am. J. Epidemiol. 127 (1988) 1155–1163 [PubMed].
  103. Trowman R., Dumville J.C., Hahn S., Torgerson D.J., A systematic review of the effects of calcium supplementation on body weight, Brit. J. Nutr. 95 (2006) 1033–1038 [CrossRef].
  104. Tuomilehto J., Lindström J., Hyyrynen J., Korpela R., Karhunen M.L., Mikkola L., Jauhiainen T., Seppo L., Nissinen A., Effect of ingesting sour milk fermented using Lactobacillus helveticus bacteria producing tripeptides on blood pressure in subjects with mild hypertension, J. Hum. Hypertens. 18 (2004) 795–802 [CrossRef] [PubMed].
  105. Vedamuthu E.R., Washam C., Cheese, in: Reed G. (Ed.), Biotechnology, Verlag Chemie, Weinheim, Germany, 1983, pp. 231–313.
  106. Vesper H., Schmelz E.M., Nikolova-Karakashian M.N., Dillehay D.L., Lynch D.V., Merrill A.H., Sphingolipids in food and the emerging importance of sphingolipids to nutrition, J. Nutr. 129 (1999) 1239–1250 [PubMed].
  107. Wang Y.W., Jones P.J.H., Dietary conjugated linoleic acid and body composition, Am. J. Clin. Nutr. 79 (2004) 1153S–1158S [PubMed].
  108. Watras A.C., Buchholz A.C., Close R.N., Zhang Z., Schoeller D.A., The role of conjugated linoleic acid in reducing body fat and preventing holiday weight gain, Int. J. Obes. 31 (2007) 481–487 [CrossRef].
  109. Wehrmüller K., Occurrence and biological properties of sphingolipids – a review, Curr. Nutr. Food Sci. 3 (2007) 161–173 [CrossRef].
  110. Willett W.C., Trans fatty acids and cardiovascular disease – epidemiological data, Atherosclerosis, Suppl. 7 (2006) 5–8.
  111. Willett W.C., Stampfer M.J., Manson J.E., Colditz G.A., Speizer F.E., Rosner B.A., Sampson L.A., Hennekens C.H., Intake of trans fatty acids and risk of coronary heart disease among women, Lancet 341 (1993) 581–585 [CrossRef] [PubMed].
  112. World Cancer Research Fund/American Institute for Cancer Research, Food, nutrition, physical activity, and the prevention of cancer: a global perspective, Washington DC, AICR (2007) 1–537.
  113. Zemel M.B., Calcium and dairy modulation of obesity risk, Obes. Res. 13 (2005) 192–193 [CrossRef] [PubMed].
  114. Zemel M.B., Miller S.L., Dietary calcium and dairy modulation of adiposity and obesity risk, Nutr. Rev. 62 (2004) 125–131 [CrossRef] [PubMed].
  115. Zemel M.B., Shi H., Greer B., DiRienzo D., Zemel P.C., Regulation of adiposity by dietary calcium, FASEB J. 14 (2000) 1132–1138 [PubMed].

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.